Analyst firms · Wolfe Research · NOC

Wolfe Research NOC price target and rating history

Northrop Grumman Corporation (NOC) · Industrials

Wolfe Research rates Northrop Grumman Corporation (NOC) Peer Perform with a $450 price target, as of its latest action on Feb 3, 2025. It has published 6 rating actions on NOC since October 2021, including 1 upgrade and 3 downgrades. Across 10 firms with a NOC price target in the last 12 months, the median target is $658.

Current rating
Peer Perform
Price target
$450
Median target, all firms
$658
Actions on NOC
6

Wolfe Research price target on NOC

$565$501$43720222023202420252026
Wolfe Research price target on NOC, each point a stated target, October 2021 to December 2023.

Every Wolfe Research rating on NOC

How other firms rate NOC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Robert W. BairdOutperform$675Oct 21, 2026
BarclaysUnderweight$419Oct 9, 2026
Rothschild & Co RedburnBuy$680Oct 6, 2026
RBC Capital MarketsSector Perform$525Oct 2, 2026
GuggenheimBuy$612Sep 15, 2026
Wells FargoOverweight$800Apr 1, 2026
Truist SecuritiesHold$623Jan 9, 2026
Alembic Global AdvisorsOverweight$662Dec 15, 2025
CitigroupBuy$654Dec 12, 2025
BNP Paribas ExaneOutperform$710Nov 18, 2025

Questions about Wolfe Research and NOC

What is Wolfe Research's price target for NOC?
Wolfe Research's latest stated price target for Northrop Grumman Corporation (NOC) is $450, from its action on Dec 14, 2023.
What is Wolfe Research's rating on NOC?
Wolfe Research rates NOC Peer Perform, a neutral rating, as of Feb 3, 2025.
When did Wolfe Research last change its view on NOC?
On Feb 3, 2025, Wolfe Research upgrades to Peer Perform from Underperform.
How does Wolfe Research's NOC target compare with other analysts?
Across 10 firms with a NOC price target in the last 12 months, the median target is $658.

More NOC rating histories

All Wolfe Research ratingsNOC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.